More than 180 people, including 13 US military personnel, were killed in the attack last August
The US government has offered a $10 million reward for information which could lead to the arrest or identification of those behind the Kabul Airport bombing in August 2021, which killed 13 US military personnel.
Gentry Smith, the assistant secretary of state for diplomatic security, announced on Monday that the State Department’s ‘Rewards for Justice Program’ would provide up to $10 million for “information leading to the arrest or conviction in any country of those responsible for the August 26, 2021 terrorist attack at Kabul’s international airport.”
He also announced a separate reward of up to $10 million for “information leading to the identification or location of ISIS-K leader Sanaullah Ghafari,” who he claimed is “responsible for approving all ISIS-K operations throughout Afghanistan.”
The August 26, 2021 bombing at Kabul Airport took place as the US military evacuated its personnel and allies from Afghanistan – leaving the Taliban to take over the capital. A total of 13 US military service members and more than 160 civilians were killed in the attack – for which ISIS-K claimed responsibility – while over 150 were injured. At least 28 members of the Taliban were also reportedly killed.
Christopher A. Landberg, the acting principal deputy coordinator for the Bureau of Counterterrorism, acknowledged on Monday that the Taliban are themselves “enemies of ISIS-K and have been very motivated to go after” the terrorist organization “as they have been doing and they did certainly in previous years.”
Landberg said the US government was “in communication” with the Taliban, which had “been working to counter” ISIS-K in Afghanistan.
Împotriva articolelor redacției noastre, persoanele nemulțumite pot formula Contestație în termen de 10 zile de la publicarea articolului, la judecătoria Orășenească nr. 1 München Bayern Deutschland, in conformitate cu Legea federală Germană. Considerăm că nu se pot formula acțiuni la instanțele din România deoarece nici o persoană care activează în trustul nostru nu poate fi extrasă de sub jurisdicția federală germană. Considerăm că redacția noastră nu răspunde în fața autorităților din România ci doar celor federale sau civile germane. deoarece legea română nu are efecte de extraneitate asupra redacției chiar dacă subiectul știrilor face obiectul unor evenimente sau persoane din România și sunt scrise în limba română. Limba română nu este izvor de extraneitate a legii.
absolvent WEB DESIGN Academia Britanică de Comunicare Iasi - absolvent COMUNICARE IN AFACERI Academia Britanica de Afaceri si Comunicare -absolvent JURNALISM EDITORIAL - London School University - 2019 inscris la echivalare diploma la Universitatea Politehnica Timisoara - absolvent studii de Drept Universitatea Europeană Drăgan, cursuri in Drept la Universitatea de Vest Timisoara, absolvent studii de proiectare, pastor coordonator in Biserica Protestanta Evanghelica,
Android Developer pe Google Play și plugin developer la Oxwall, creator de teme Wordpress și Oxwall, operator Wordpress, Drupal, Oxwall, Osclass, Moodle, tehnologii HTML și PHP
Amid the ongoing battle against Covid-19, the World Health Organization has approved the first ever vaccine against another deadly disease – Malaria. The WHO believes the jab could be used to save tens of thousands of lives. “The World Health Organization is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan […]
The network’s hosts lament that people are ignoring mainstream messaging on Covid-19 and ‘living their lives’ CNN has turned introspective, apparently discovering that most Americans have tuned out its coverage of the Covid-19 pandemic, reflecting a disconnect between legacy media outlets and the general public. Host Brian Stelter broached the subject on Monday, asking whether […]
The European Medicines Agency has approved two new Covid-19 treatments: an antibody medication and an arthritis drug that turned out to be able to “reduce” the inflammation associated with the virus. The first drug, Xevudy, produced by GlaxoSmithKline and Vir Biotechnology was recommended for treating the virus in adults and adolescents older than 12 who […]
